Zevia (NYSE:ZVIA) on Tuesday said it has received notice from the New York Stock Exchange informing the company that it is no longer in compliance with listing standards as the average closing price of the company’s Class A common stock was less than $1.00 per share over a consecutive 30Continue Reading
Love Employee Eisai (OTCPK:ESALF) has received the rights back to antibody drug conjugate farletuzumab ecteribulin (FZEC) after Bristol-Myers Squibb (NYSE:BMY) ended a strategic collaboration on the candidate. The Japanese pharma said it will accelerate development of the asset on its own. Eisai (ESAIY) has an ongoing phase 1 study inContinue Reading
Mobilicom (NASDAQ:MOB) on Friday announced it has received a notification of non-compliance from Nasdaq of not meeting the minimum bid price requirement for continued listing on the exchange. The closing bid price for the company’s American Depositary Shares listed on the Nasdaq was below USD $1.00 for 30 consecutive tradingContinue Reading
Yoshiharu Global Co. (NASDAQ:YOSH) on Thursday said it has received a letter from Nasdaq, notifying the company that because it has not yet filed its Form 10-Q for the quarter ended March 31, 2024, Nasdaq has determined that the company has failed to comply with the filing requirement for continued listing.Continue Reading
